Procter & Gamble Health Limited has formally notified stock exchanges that it does not qualify as a 'Large Corporate' under the Securities and Exchange Board of India's framework for fund raising by large entities. The disclosure was made to both BSE and NSE on April 6, 2026, through Company Secretary Zeal Rupani.

Regulatory Compliance Framework

The company's disclosure relates to SEBI Circular No SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, along with subsequent amendments, including the latest circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated April 13, 2022. These circulars establish requirements for disclosure of fund raising by issuance of debt securities by large entities.

Company Financial Position

Procter & Gamble Health Limited provided specific details regarding its financial status in the mandatory disclosure format:

SEBI Framework Implications

Under the SEBI framework, entities classified as Large Corporates are subject to specific borrowing requirements through debt securities. The regulations include provisions for fines in case of shortfall in mandatory borrowing through debt markets. Beginning from FY2022, a fine of 0.20% of the shortfall is levied by stock exchanges at the end of the two-year block period.

Corporate Governance

The disclosure was signed digitally by Company Secretary Zeal Rupani on April 6, 2026, at 10:33:45 +05'30'. The company has requested both BSE and NSE to acknowledge receipt of this compliance disclosure, demonstrating adherence to regulatory transparency requirements.

Procter & Gamble Health Limited has filed its quarterly compliance certificate with stock exchanges, confirming adherence to regulatory requirements for the quarter ended March 31, 2026. The submission was made on April 6, 2026, addressing obligations under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Confirmation

The company submitted certificates to both BSE Limited and National Stock Exchange of India Limited, confirming compliance with Regulation 74(5) of SEBI regulations. Company Secretary Zeal Rupani signed the compliance documents, which were digitally authenticated on April 6, 2026.

Registrar Confirmation

Kfin Technologies Limited, serving as the company's Registrar and Transfer Agent, provided written confirmation of compliance. The registrar certified that details of securities dematerialized and rematerialized during the quarter were furnished to all stock exchanges where the company's shares are listed within prescribed timelines.

Ganesh Chandra Patro, Deputy Vice President at Kfin Technologies Limited, signed separate certificates addressed to both Central Depository Services (India) Limited and National Securities Depository Limited on April 1, 2026.

Stock Exchange Submissions

The compliance certificates were submitted to major Indian stock exchanges where Procter & Gamble Health Limited shares are traded. The filings ensure transparency in share dematerialization processes and maintain regulatory compliance standards.

This quarterly filing represents standard regulatory practice for listed companies, ensuring proper documentation and transparency in share transfer and dematerialization activities. The timely submission demonstrates the company's commitment to maintaining regulatory compliance and transparent reporting practices.